BIFIDO Co., Ltd. (238200.KQ)
KOSDAQ · KRW · Consumer Defensive · Packaged Foods
₩2,490 (+4.40%) as of
Key statistics
- Market cap
- 20.37B
- Dividend yield
- 0.00%
- 52-week range
- 2,045.00 – 3,995.00
- Beta
- 0.94
- Revenue (TTM)
- 14.63B
- Profit margin
- 12.64%
- Volume
- 2.26k
About BIFIDO Co., Ltd.
BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Headquarters
- Hongcheon-eup, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.